Award
National Institutes of Health 1R56DE033513-01A1
Fibronectin Modulation of Oral Cancer Nociception
Recipient
New York University
Award Amount
$672,660.00
Ceiling
$672,660.00
Awarded
August 21, 2025
Identifier
1R56DE033513-01A1
Research project focused on understanding fibronectin's role in oral cancer pain and developing non-opioid pain treatments.
Description
The project aims to elucidate the role of FN1 and Fn EDA as pain mediators in oral cancer, with objectives including profiling, functional evaluation, and mechanistic studies. The research involves clinical samples, cell lines, and mouse models. The goal is to develop non-opioid pain management strategies for oral cancer.